steve aselage  professional profile linkedin main content starts below steve aselageceo retrophinlocationgreater san diego areaindustrybiotechnologycurrentretrophin acer therapeutics incpreviousbiomarin pharmaceutical inc apt pharmaceuticals renwoodeducationuniversity of notre dame connectionsview steve’s full profile its freeyour colleagues classmates and  million other professionals are on linkedinview steve’s full profilesteve’s activityjust the push many entrepreneurs need i know a lot ofsteve likedexperiencechief executive officerretrophinoctober  – present  years  monthschairman of the boardacer therapeutics incjanuary  – present  year  monthsboard of directorsretrophinoctober  – present  years  monthsevp  cbobiomarin pharmaceutical inc – october   yearsboard of directorsapt pharmaceuticals –   yearsdirectorrenwood –   yearssr vp sales and marketingcell therapeutics inc –   yearvp sales and marketingsangstat medical –   yearsvp sales and marketingsangstat medical corporationgenzyme –   yearsvp north america sales and marketingsangstat –   yearsdirector of sales and marketingadvanced tissue sciences –   yearsdirector of salesrpr oncology –   yeardirector of salesboehringer mannheim –   yeardirector salesgenentech –   yearsskillsoncologyfdapharmaceutical industrybiotechnologypharmaceutical salesbusiness developmentsales managementlifesciencescrossfunctional team leadershipmanaged caremarketing strategygmpmedical devicesstrategyproduct launchsee commercializationclinical trialsstartupsstrategic planningregulatory affairsproduct developmentcardiologysaleshematologysales effectivenessinfectious diseasesdrug developmentvaccinestechnology transferimmunologyvalidationsee lesshows this translationgreat•has errorsthanks for your helpeducationuniversity of notre damebs biologybs biology – groupsorphan pharmaceuticals  biopharmaceuticals groupconstruction careers  middle eastsoftware  technology  in jobs hr managers cloud mobile voice crm  big datajobsjam  construction recruitment eventsnotre dame scienceview steve’s full profile tosee who you know in commonget introducedcontact steve directlyview steve’s full profilenot the steve you’re looking for view moreview this profile in another languageenglishgermanchinese simplifiedpeople also viewedkeller perryexecutive assistant to managing director at general catalyst partnersedwin urrutiaretired president and ceo of nothing jennifer huntvice president development operations at retrophinmartin shkreliceo at godel systems inc founder at turing pharmaceuticals agjane pitluckmartin shkreliceo on indefinite leave of absencedeanna greenacting general counsel at turing pharmaceuticals agmark cubanpresidentnancy retzlaffsenior commercial leader  pharmaceutical  biotech industrysean parkerpublic profile badgeinclude this linkedin profile on other websitesview profile badgesfind a different steve aselagefirst namelast nameexample steve aselagesteve aselageunited statesmore professionals named steve aselagelinkedin member directoryabcdefghijklmnopqrstuvwxyzmorebrowse members by country stephen aselage retrophin inc profile  biography  bloomberg feedback stephen steve aselage presidentceo retrophin inc career history presidentceo retrophin inc present presidentinterim ceocoo retrophin inc  presidentcoo retrophin inc  exec vpchief business officer biomarin pharmaceutical inc  senior vpglobal comm ops biomarin pharmaceutical inc  exec vpglobal commercial ops cell therapeutics inc  senior vpnorth american sales genzyme corp  senior vpnorth american sales sangstat medical corp  directorsales  marketing advanced tissue sciences inc  chief executive officer retrophin llc unknown rhonepoulenc rorer pharmaceut former genentech inc former bristol laboratories ltd former show more website wwwretrophincom corporate information address  third avenue nd floor new york ny  united states phone  fax  web url wwwretrophincom from the web personal information education university of notre dame bachelors degree biology memberships board memberships retrophin inc board member present apt pharmaceuticals inc board member present sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data steve aselage  patara pharma bod steve aselage mr aselage is the ceo of retrophin inc and a member of its board of directors prior to retrophin mr aselage was evp and cbo of biomarin pharmaceutical inc during his seven years with biomarin he built the commercial and medical affairs functions that launched three commercial products and developed commercial businesses in more than  countries mr aselage has also held leadership roles with cell therapeutics sangstat medical corporation advanced tissue sciences and genentech he worked briefly for genzyme as well assisting in the transition following its acquisition of sangstat earlier in his career he held a variety of sales and sales management positions at companies including rhonepoulenc rorer pharmaceuticals now sanofiaventis and bristol laboratories mr aselage received a bs in biology from the university of notre dame menu home disease product about news contact access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id deeecfd powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id cbeeeedbeaaedd powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id bbeeebbcc powered by perimeterx  inc retrophin inc names stephen aselage president and chief operations officer employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       retrophin inc rtrx names stephen aselage president and chief operations officer tweet   am retrophin inc nasdaqrtrx today announced the appointment of stephen aselage as president and chief operations officer effective immediately in his new role mr aselage will be responsible for managing corporate development activities including the commercialization of existing products building out the company’s global infrastructure and exploring new business development opportunities “steve has been a trusted advisor to retrophin since our formation having served as a key member of our board of directors” said martin shkreli founder and ceo of retrophin “i have no doubt that the expertise steve has accumulated during his more than year career in the global pharmaceutical industry will be invaluable as we continue advancing our pipeline of treatments for catastrophic diseases and expanding our commercial product portfolio through strategic transactions” “i’ve been impressed with martin’s progress in building retrophin over the past year and a half” said mr aselage “as president and chief operations officer i look forward to sustaining this growth and helping the company realize the full potential of its promising treatments for rare and often lifethreatening diseases” prior to joining retrophin in  mr aselage was executive vice president and chief business officer at biomarin pharmaceutical inc there he built the commercial and medical affairs functions that launched three commercial products and developed commercial business in more than  countries mr aselage has also held leadership roles with sangstat medical corporation and genentech he worked briefly for genzyme as well assisting in the transition following its acquisition of sangstat earlier in his career he held a variety of sales and sales management positions at companies including rhonepoulenc rorer pharmaceuticals now sanofiaventis and bristol laboratories mr aselage received his bs in biology from the university of notre dame about retrophin retrophin is a pharmaceutical company focused on the development acquisition and commercialization of drugs for the treatment of serious catastrophic or rare diseases for which there are currently no viable options for patients the companys marketed products include chenodal® and vecamyl® and its pipeline includes compounds for several catastrophic diseases including focal segmental glomerulosclerosis fsgs pantothenate kinaseassociated neurodegeneration pkan schizophrenia autism infantile spasms nephrotic syndrome and others retrophin intends to reintroduce syntocinon nasal spray in the us to assist initial postpartum milk ejection for additional information please visit wwwretrophincom forwardlooking statements this press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and commercialization of pharmaceutical products without limiting the foregoing these statements are often identified by the words may might believes thinks anticipates plans expects intends or similar expressions in addition expressions of our strategies intentions or plans are also forwardlooking statements such forwardlooking statements are based on current expectations and involve inherent risks and uncertainties including factors that could delay divert or change any of them and could cause actual outcomes and results to differ materially from current expectations no forwardlooking statement can be guaranteed forwardlooking statements in the press release should be evaluated together with the many uncertainties that affect the companys business you are cautioned not to place undue reliance on these forwardlooking statements as there are important factors that could cause actual results to differ materially from those in forwardlooking statements many of which are beyond our control the company undertakes no obligation to publicly update any forwardlooking statement whether as a result of new information future events or otherwise investors are referred to the full discussion of risks and uncertainties as included in the companys filings with the securities and exchange commission contacts retrophin inc marc panoff  cfo marcretrophincom help employers find you check out all the jobs and post your resume read at biospacecom related news retrophin llc rtrx initiates global access for re in pantothenate kinaseassociated neurodegeneration pkan organization changes at celgene celg have got investors wondering who will take over once hugin steps down retrophin llc rtrx completes acquisition of manchester pharmaceuticals inc update genelux corporation announces former amgen amgn and abbott laboratories abt executives to succeed founder aladar a szalay phd as ceo chairman of the board retrophin llc rtrx plunks down  million for manchester pharmaceuticals inc cleveland biolabs inc cbli cuts pay for cofounders and directors to conserve cash retrophin llc rtrx reports first quarter  financial results new filings reveal how pfizer inc pfe executives made millions before bid for astrazeneca plc azn biotech retrophin llc rtrx files for  million ipo oxigene oxgn names experienced biotech executive david j chaplin phd as president and chief executive officer please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • retrophin inc   • biotechpharma  personnel                 stephen aselage  biomarin pharmaceutical inc  zoominfocom retrophin announces appointment of stephen aselage as ceo employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       retrophin rtrx announces appointment of stephen aselage as ceo tweet   am new yorkbusiness wireretrophin inc nasdaqrtrx today announced that the board of directors has appointed stephen aselage as chief executive officer ceo effective immediately mr aselage has been serving as the company’s interim ceo since september   “steve has done an excellent job of guiding retrophin through a period of significant change” said steve richardson chairman of the board of directors “he has demonstrated compelling leadership and vision while working with the board and management team to develop a plan that maximizes our commercial capabilities and focuses development efforts on assets with the highest potential returns the board is delighted that steve has agreed to continue to lead retrophin and execute our newly focused strategic plan” “i am honored to have the opportunity to continue working with the talented team at retrophin as we bring lifechanging treatments to our patients and value to our shareholders” said mr aselage “i’ve gained a tremendous appreciation for our exceptional rd capabilities commercial talent and highly effective business development efforts all of which position retrophin for continued success” mr aselage has more than  years of pharmaceutical and biotechnology experience most recently he was executive vice president and chief business officer of biomarin pharmaceutical inc during his seven years with biomarin he built the commercial and medical affairs functions that launched three commercial products and developed commercial businesses in more than  countries mr aselage has also held leadership roles with cell therapeutics sangstat medical corporation advanced tissue sciences and genentech he worked briefly for genzyme as well assisting in the transition following its acquisition of sangstat earlier in his career he held a variety of sales and sales management positions at companies including rhonepoulenc rorer pharmaceuticals now sanofiaventis and bristol laboratories mr aselage received his bs in biology from the university of notre dame about retrophin retrophin is a pharmaceutical company focused on the development acquisition and commercialization of drugs for the treatment of serious catastrophic or rare diseases for which there are currently no viable options for patients the companys approved products include chenodal® thiola® and vecamyl® and its pipeline includes compounds for several catastrophic diseases including focal segmental glomerulosclerosis fsgs pantothenate kinaseassociated neurodegeneration pkan schizophrenia infantile spasms nephrotic syndrome and others for additional information please visit wwwretrophincom forwardlooking statements this press release contains forwardlooking statements as that term is defined in the private securities litigation reform act of  regarding the research development and commercialization of pharmaceutical products without limiting the foregoing these statements are often identified by the words may might believes thinks anticipates plans expects intends or similar expressions no forwardlooking statement can be guaranteed you are cautioned not to place undue reliance on these forwardlooking statements as there are important factors that could cause actual results to differ materially from those in forwardlooking statements many of which are beyond our control the company undertakes no obligation to publicly update forwardlooking statements whether as a result of new information future events or otherwise investors are referred to the full discussion of risks and uncertainties as included in the companys filings with the securities and exchange commission contacts retrophin inc marc panoff  cfo marcretrophincom or chris cline cfa  manager investor relations irretrophincom help employers find you check out all the jobs and post your resume read at biospacecom related news retrophin rtrx announces divestment of noncore assets to turing pharmaceuticals salix pharmaceuticals ltd slxp plummets as accounting scandal sinks deal with allergan inc agn cfo resigns retrophin rtrx booted ceo for multiple stock violations report firing of sanofi sanpa ceo mirrors teva pharmaceutical industries limited tevas  shakeup retrophin inc rtrx gilead sciences inc gild and our healthcare values sanofi sanpa ousts ceo after clash over strategy retrophin inc rtrx announces leadership reorganization lpath inc lptn ceo steps down retrophin rtrx reports inducement grants under nasdaq listing rule c sanofi sanpa approached astrazeneca plc azns soriot for ceo role please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • retrophin inc   • biotechpharma  personnel                 access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id cbeeebbccdb powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id eeeebdefebcc powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id dbaeeebfdcafb powered by perimeterx  inc  aselage profiles  linkedin linkedin main content starts below aselage profilesshare on linkedinshare on facebookshare on twittershare on googlepublic profilesteve aselageceo retrophinlocationgreater san diego areaindustrybiotechnologycurrentchief executive officer at retrophin chairman of the board at acer therapeutics inc board of directors at retrophinpastevp  cbo at biomarin pharmaceutical inc board of directors at apt pharmaceuticals director at renwood sr vp sales and marketing ateducationuniversity of notre dameview full profilepublic profileelizabeth aselagepatient advocacy  alliance development specialist at retrophinlocationgreater san diego areaindustrybiotechnologycurrentpatient advocacy  alliance development specialist at retrophin discovery  translational research analyst at retrophin businesspastmuseum officer at michigan state university public services intern at lansing police department court officer at th judicial circuiteducationmichigan state universitysummaryemerging leader in the healthcare industry with expertise in strategic partnerships and program development from experiences working in theview full profilepublic profilehollie aselagebenefits supervisor at bbrglocationcolumbus ohio areaindustryhuman resourcescurrentbenefits supervisor at bravo brio restaurant grouppasthuman resources generalist at charleys grilled subs human resourcespayroll manager at rite rug human resources coordinator at bareeducationthe ohio state universitysummaryhighly motivated and compassionate human resources professional with several years of experience managing a full spectrum of human resourceview full profilepublic profilesusan aselageboard member treasurer at st louis makeslocationgreater st louis areaindustryexecutive officecurrentboard member treasurer at st louis makes co owner at seabury farmpastpresident and vice chairman of the board at sabreliner corporation vice chairman of the board at sabreliner corporation vice presidenteducationwashington university in st louis  olin business school hobart and william smith colleges concord academysummarysusan joined sabreliner corporation at its inception in  as its of the original investors her role as president included developingview full profilepublic profilejenney aselagebusiness analyst at wells fargo advisorslocationgreater st louis areaindustryfinancial servicescurrentbusiness analyst at wells fargo advisorspastfinance management associate program intern at bank of america intern at armstrong teasdale llpeducationuniversity of virginia mary institute and st louis country day schoolview full profilepublic profilejustin aselagesenior director business intelligence  finance at corporate executive boardlocationwashington dc metro areaindustrymanagement consultingcurrentsenior director business intelligence  finance at corporate executive boardpastdirector  assoc director business intelligence at corporate executive board senior quantitative analyst at corporate executive boardeducationuniversity of delaware university of toledosummaryspecialties wellversed in predictive analytic and data mining techniques including multivariate regression logistic regression anovaview full profilepublic profilemaria aselagecrisis communicationspr consultantlocationcharleston south carolina areaindustrypublic relations and communicationscurrentowner at hearsay communications adjunct professordirector of communications  marketing  school of business administration at thepastexecutive vice president at clay county chamber of commerce director of communications  information at catholic diocese ofeducationthe citadel the university of georgiasummarypublic relations professional with experience in coordinating crisis communications overseeing communication initiatives for politicalview full profilepublic profilematthew aselagelope specialist and oar student worker at grand canyon universitylocationorange county california areaindustryhigher educationpastbackoffice employee at grand canyon university lope specialist at grand canyon university secretary treasurer and public relationseducationuniversity of california irvine grand canyon universityview full profilepublic profilebrandon aselagesales associate at medtroniclocationgreater detroit areaindustrymedical devicescurrentsales associate at medtronicpastbody interior engineer at ford motor company biomechanics research intern at foundation of orthopaedic research and education fore educationuniversity of michigan  ann arbor university of michigan college of engineeringview full profilepublic profilebill aselageowner of dream vacationslocationjacksonville florida areaindustryleisure travel  tourismcurrentfranchise owner at dream vacationspastdistrict manager at toshiba america medical systems district manager at picker internationaleducationxavier university  williams college of business the ohio state university fisher college of businesssummaryi spent  years in the medical imaging field in sales and sales management i retired and needed something to fill my spare time iview full profilepublic profilejane aselageinterior trim manager  body engineering at ford motor companylocationgreater detroit areaindustryautomotivecurrentinterior trim manager  body engineering at ford motor companyview full profilepublic profilebradley aselagepilot at williams aerial  mappinglocationlima ohio areaindustryinformation technology and servicescurrentflight ops director of special missions at williams aerial  mappingpastaerial advertisement pilot at boomer aviationeducationsinclair community collegesummarydirector of special mission to make sure employees are able to operate high performance aircraft in photo mission based survey overview full profilepublic profilescott aselage cpimplant manager at hendricksonlocationfort wayne indiana areaindustrytransportationtruckingrailroadcurrentplant manager at hendricksonpastmaterials manager at hendrickson truck suspension production manager at hendrickson truck suspension production supervisor at hendricksoneducationindiana universitypurdue university at fort wayne tristate universityview full profilepublic profilejohn aselage aa orchardlocationfayetteville arkansas areaindustryfood productioncurrentsemi retired at aa orchardpastmanager organic agriculture at amys kitchen inc ramp risk avoidance and mitigation panel manager at usda agricultural research andeducationmichigan state university university of missouricolumbia antioch collegeview full profilepublic profilemason aselagesales associate at onesource solutionslocationgreater st louis areaindustrymarketing and advertisingcurrentcare coordinator at driftwood recoverypastsales associate at onesource solutionseducationtexas tech university ladue horton watkins texas tech university texas tech universityview full profilepublic profileterry aselagelocationunited statesview full profilepublic profilestephanie aselageenvironmental scientist at chm hilllocationcincinnati area kyindustryenvironmental servicescurrentenvironmental scientist at chm hillpastresearch associate at university of michigan environmental scientist at ljb inceducationuniversity of michigan wright state universityview full profilepublic profilegregory aselageapplication engineerlocationcincinnati area kyindustrycomputer softwarecurrentapplication engineer at northrop grumman corporationeducationwright state universityview full profilepublic profilejenifer aselageenvironmental engineer at engineering  environmental solutionslocationfort wayne indiana areaindustryenvironmental servicescurrentenvironmental engineer at engineering  environmental solutionspastenvironmental engineer at avant group environmental engineer at rivers bend engineeringeducationtristate universityview full profilepublic profilejoyce aselagequality laboratory supervisor at the dannon companylocationlima ohio areaindustryconsumer goodscurrentquality laboratory supervisor at the dannon companyeducationwright state university urbana universityview full profilepublic profiledarci aselageself employedlocationdayton ohio areaindustrymanagement consultingpastclient services managerbusiness mentor at the edge retail academy vice president at harris jewelereducationanna high schoolview full profilepublic profileclem aselagelocationunited statesview full profilepublic profilekarl aselagesales at weingartz supplylocationgreater detroit areaindustrymachinerycurrentsales at weingartz supplypastowner at bighorn products westland mall westland mich sales at allen ford of west bloomfield mi owner at execucare landscape coeducationst louis university loyola university new orleansview full profilepublic profilerick aselagepartner at rubinbrown llplocationgreater st louis areaindustryaccountingcurrentpartner at rubinbrown llpeducationuniversity of notre dameview full profilepublic profilesteve aselagelocationsan francisco bay areaindustrybiotechnologyview full profilejoin linkedin to see all  profilesjoin linkedinjoin linkedin to see all  profiles